ORG Wealth Partners LLC Sells 1,568 Shares of Fresenius Medical Care AG (NYSE:FMS)

ORG Wealth Partners LLC decreased its position in Fresenius Medical Care AG (NYSE:FMS) by 29.9% during the 4th quarter, HoldingsChannel reports. The fund owned 3,683 shares of the company’s stock after selling 1,568 shares during the quarter. ORG Wealth Partners LLC’s holdings in Fresenius Medical Care were worth $83,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of FMS. Rhumbline Advisers boosted its holdings in Fresenius Medical Care by 6.7% during the second quarter. Rhumbline Advisers now owns 18,067 shares of the company’s stock worth $345,000 after purchasing an additional 1,128 shares during the last quarter. Caprock Group LLC bought a new stake in Fresenius Medical Care during the 2nd quarter worth about $208,000. American Century Companies Inc. boosted its stake in shares of Fresenius Medical Care by 29.3% during the 2nd quarter. American Century Companies Inc. now owns 24,046 shares of the company’s stock worth $459,000 after buying an additional 5,445 shares during the last quarter. Dimensional Fund Advisors LP grew its holdings in shares of Fresenius Medical Care by 14.4% in the 2nd quarter. Dimensional Fund Advisors LP now owns 12,539 shares of the company’s stock valued at $239,000 after acquiring an additional 1,576 shares in the last quarter. Finally, Wulff Hansen & CO. increased its position in shares of Fresenius Medical Care by 1,809.0% in the second quarter. Wulff Hansen & CO. now owns 343,429 shares of the company’s stock valued at $6,556,000 after acquiring an additional 325,439 shares during the last quarter. Institutional investors and hedge funds own 8.37% of the company’s stock.

Fresenius Medical Care Price Performance

NYSE:FMS opened at $22.50 on Friday. Fresenius Medical Care AG has a 12-month low of $17.93 and a 12-month high of $24.31. The firm has a market capitalization of $13.20 billion, a price-to-earnings ratio of 18.60, a P/E/G ratio of 0.95 and a beta of 0.92. The stock’s 50 day moving average price is $22.50 and its two-hundred day moving average price is $20.76. The company has a quick ratio of 1.02, a current ratio of 1.37 and a debt-to-equity ratio of 0.42.

Analysts Set New Price Targets

FMS has been the subject of several recent research reports. Bank of America raised Fresenius Medical Care from an “underperform” rating to a “neutral” rating in a research report on Monday, December 2nd. Truist Financial increased their price objective on Fresenius Medical Care from $23.00 to $25.00 and gave the company a “hold” rating in a report on Monday, January 6th. Berenberg Bank began coverage on shares of Fresenius Medical Care in a report on Wednesday, November 6th. They set a “buy” rating and a $25.60 target price on the stock. Finally, StockNews.com initiated coverage on shares of Fresenius Medical Care in a research report on Friday, January 3rd. They set a “strong-buy” rating on the stock.

About Fresenius Medical Care

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.